NutriBand (NTRB) Gains from Investment Securities (2018 - 2026)
NutriBand's (NTRB) quarterly Gains from Investment Securities came in at $234584.0 in Q1 2026, up 22.98% year-on-year from $190751.0 in Q1 2025, and down 42.67% quarter-over-quarter from $409167.0 in Q4 2025.
NutriBand (NTRB) Gains from Investment Securities (2018 - 2026) Analysis & Trends
NutriBand has disclosed Gains from Investment Securities across 9 years of filings, most recently posting $234584.0 for Q1 2026.
- Gains from Investment Securities for Q1 2026 came in at $234584.0, up 22.98% year-over-year; the trailing twelve-month figure through Jan 2026 was $234584.0 (up 22.98% YoY), and the FY2026 annual result was $234584.0, up 22.98% from the prior year.
- Gains from Investment Securities came in at $234584.0 for Q1 2026 at NutriBand, down from $409167.0 in the prior quarter.
- In the past five years, Gains from Investment Securities ranged from a high of $4.2 million in Q2 2024 to a low of $30000.0 in Q2 2023.
- The 5-year median for Gains from Investment Securities is $429583.5 (2024), against an average of $818022.8.
- Across the five-year window, Gains from Investment Securities soared 13900.0% in 2024 and tumbled 78.2% in 2025, its largest moves.
- NutriBand's Gains from Investment Securities stood at $106031.0 in 2022, then soared by 281.49% to $404500.0 in 2023, then grew by 11.25% to $450000.0 in 2024, then retreated by 9.07% to $409167.0 in 2025, then sank by 42.67% to $234584.0 in 2026.
- The last three Gains from Investment Securities figures came in at $234584.0 (Q1 2026), $409167.0 (Q4 2025), and $1.4 million (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 788,338.31 Bn | 788,338.28 Bn | - |
| 2 | Belite Bio | 56,560.00 Bn | 56,560.00 Bn | - |
| 3 | Quantum Biopharma | 17,329.30 Bn | 17,329.30 Bn | - |
| 4 | Legend Biotech | 3,341.00 Bn | 3,340.71 Bn | 242.10 Mn |
| 5 | Akari Therapeutics | 1,727.91 Bn | 1,727.91 Bn | - |
| 6 | Evaxion A | 1,536.68 Bn | 1,536.67 Bn | - |
| 7 | Psyence Biomedical | 238.34 Bn | 238.33 Bn | - |
| 8 | Vertex Pharmaceuticals | 113.42 Bn | 106.17 Bn | 2.59 Bn |
| 9 | Abivax | 95.45 Bn | 95.45 Bn | - |
| 10 | NutriBand | 41.21 Mn | 36.63 Mn | 88,941.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jan 31, 2026 | 234,584.00 |
| Jan 31, 2026 | 234,584.00 |
| Oct 31, 2025 | 409,167.00 |
| Oct 31, 2025 | 409,167.00 |
| Jul 31, 2025 | 1.35 Mn |
| Jul 31, 2025 | 1.35 Mn |
| Apr 30, 2025 | 1.37 Mn |
| Apr 30, 2025 | 1.37 Mn |
| Jan 31, 2025 | 190,751.00 |
| Jan 31, 2025 | 190,751.00 |
| Oct 31, 2024 | 450,000.00 |
| Oct 31, 2024 | 450,000.00 |
| Jul 31, 2024 | 1.32 Mn |
| Jul 31, 2024 | 1.32 Mn |
| Apr 30, 2024 | 4.20 Mn |
| Apr 30, 2024 | 4.20 Mn |
| Jan 31, 2024 | 874,835.00 |
| Jan 31, 2024 | 874,835.00 |
| Oct 31, 2023 | 404,500.00 |
| Oct 31, 2023 | 404,500.00 |